• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症中的DNA甲基化:过多,但也过少。

DNA methylation in cancer: too much, but also too little.

作者信息

Ehrlich Melanie

机构信息

Human Genetics Program/SL31, Department of Biochemistry, Tulane Medical School, New Orleans, Louisiana, LA 70122, USA.

出版信息

Oncogene. 2002 Aug 12;21(35):5400-13. doi: 10.1038/sj.onc.1205651.

DOI:10.1038/sj.onc.1205651
PMID:12154403
Abstract

Cancer-associated DNA hypomethylation is as prevalent as cancer-linked hypermethylation, but these two types of epigenetic abnormalities usually seem to affect different DNA sequences. Much more of the genome is generally subject to undermethylation rather than overmethylation. Genomic hypermethylation in cancer has been observed most often in CpG islands in gene regions. In contrast, very frequent hypomethylation is seen in both highly and moderately repeated DNA sequences in cancer, including heterochromatic DNA repeats, dispersed retrotransposons, and endogenous retroviral elements. Also, unique sequences, including transcription control sequences, are often subject to cancer-associated undermethylation. The high frequency of cancer-linked DNA hypomethylation, the nature of the affected sequences, and the absence of associations with DNA hypermethylation are consistent with an independent role for DNA undermethylation in cancer formation or tumor progression. Increased karyotypic instability and activation of tumor-promoting genes by cis or trans effects, that might include altered heterochromatin-euchromatin interactions, may be important consequences of DNA hypomethylation which favor oncogenesis. The relationship of DNA hypomethylation to tumorigenesis is important to be considered in the light of cancer therapies involving decreasing DNA methylation. Inducing DNA hypomethylation may have short-term anticancer effects, but might also help speed tumor progression from cancer cells surviving the DNA demethylation chemotherapy.

摘要

癌症相关的DNA低甲基化与癌症相关的高甲基化一样普遍,但这两种表观遗传异常通常似乎会影响不同的DNA序列。一般来说,基因组中发生低甲基化的部分比高甲基化的部分更多。癌症中的基因组高甲基化最常出现在基因区域的CpG岛中。相比之下,在癌症中,高度和中度重复的DNA序列,包括异染色质DNA重复序列、分散的逆转座子和内源性逆转录病毒元件,都经常出现低甲基化。此外,独特序列,包括转录控制序列,也常常发生与癌症相关的低甲基化。癌症相关的DNA低甲基化的高频率、受影响序列的性质以及与DNA高甲基化缺乏关联,都与DNA低甲基化在癌症形成或肿瘤进展中的独立作用相一致。核型不稳定性增加以及通过顺式或反式效应激活促肿瘤基因,这可能包括改变异染色质-常染色质相互作用,可能是有利于肿瘤发生的DNA低甲基化的重要后果。鉴于涉及降低DNA甲基化的癌症治疗方法,考虑DNA低甲基化与肿瘤发生的关系非常重要。诱导DNA低甲基化可能具有短期抗癌作用,但也可能有助于加速经受DNA去甲基化化疗后存活的癌细胞的肿瘤进展。

相似文献

1
DNA methylation in cancer: too much, but also too little.癌症中的DNA甲基化:过多,但也过少。
Oncogene. 2002 Aug 12;21(35):5400-13. doi: 10.1038/sj.onc.1205651.
2
DNA methylation and gene silencing in cancer: which is the guilty party?癌症中的DNA甲基化与基因沉默:哪一方是罪魁祸首?
Oncogene. 2002 Aug 12;21(35):5380-7. doi: 10.1038/sj.onc.1205598.
3
Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours.癌症作为一种表观遗传疾病:人类肿瘤中的DNA甲基化与染色质改变
J Pathol. 2002 Jan;196(1):1-7. doi: 10.1002/path.1024.
4
Causes and consequences of DNA hypomethylation in human cancer.人类癌症中DNA低甲基化的原因及后果
Biochem Cell Biol. 2005 Jun;83(3):296-321. doi: 10.1139/o05-036.
5
Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers.染色体不稳定性与人类原发性结直肠癌全基因组DNA去甲基化相关。
Cancer Res. 2006 Sep 1;66(17):8462-9468. doi: 10.1158/0008-5472.CAN-06-0293.
6
Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells.转录基因沉默通过癌细胞中染色质修饰的顺序变化促进DNA高甲基化。
Cancer Res. 2004 Jun 1;64(11):3871-7. doi: 10.1158/0008-5472.CAN-03-3690.
7
Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.前列腺腺癌中CpG岛位点的高甲基化及长散在核元件1(LINE-1)和短散在核元件(Alu)重复序列的低甲基化及其与临床病理特征的关系
J Pathol. 2007 Feb;211(3):269-77. doi: 10.1002/path.2106.
8
DNA demethylation and cancer: therapeutic implications.DNA去甲基化与癌症:治疗意义
Cancer Lett. 2004 Aug 10;211(2):133-43. doi: 10.1016/j.canlet.2004.04.009.
9
Silencing of bidirectional promoters by DNA methylation in tumorigenesis.肿瘤发生过程中DNA甲基化对双向启动子的沉默作用。
Cancer Res. 2006 May 15;66(10):5077-84. doi: 10.1158/0008-5472.CAN-05-2629.
10
Promoter hypermethylation profile of kidney cancer.肾癌的启动子高甲基化图谱
Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):3972-9. doi: 10.1158/1078-0432.CCR-04-0175.

引用本文的文献

1
Global Hypomethylation as Minimal Residual Disease (MRD) Biomarker in Esophageal and Esophagogastric Junction Adenocarcinoma.全基因组低甲基化作为食管及食管胃交界腺癌微小残留病(MRD)生物标志物
Cancers (Basel). 2025 Aug 15;17(16):2668. doi: 10.3390/cancers17162668.
2
Decoding the Epigenome: Comparative Analysis of Uterine Leiomyosarcoma and Leiomyoma.解读表观基因组:子宫平滑肌肉瘤与平滑肌瘤的比较分析
Cancers (Basel). 2025 Aug 9;17(16):2610. doi: 10.3390/cancers17162610.
3
DNA 5mC methylation inhibits the formation of G-quadruplex structures in the genome.
DNA 5-甲基胞嘧啶甲基化抑制基因组中G-四链体结构的形成。
Genome Biol. 2025 Jul 11;26(1):202. doi: 10.1186/s13059-025-03678-4.
4
Plasma and Urine Circulating Tumor DNA Methylation Profiles for Non-Invasive Pancreatic Ductal Adenocarcinoma Detection: Significant Findings in Plasma Only.用于无创检测胰腺导管腺癌的血浆和尿液循环肿瘤DNA甲基化谱:仅血浆中的重要发现。
Int J Mol Sci. 2025 May 22;26(11):4972. doi: 10.3390/ijms26114972.
5
Fibroblast activation protein-α is a potential prognostic biomarker related to ferroptosis in head and neck squamous cell carcinoma.成纤维细胞活化蛋白-α是一种与头颈部鳞状细胞癌中铁死亡相关的潜在预后生物标志物。
Biochem Biophys Rep. 2025 May 15;42:102046. doi: 10.1016/j.bbrep.2025.102046. eCollection 2025 Jun.
6
TERT promoter methylation predicts overall survival, immune cell infiltration and response to immunotherapy in clear cell renal cell carcinoma.端粒酶逆转录酶(TERT)启动子甲基化可预测透明细胞肾细胞癌的总生存期、免疫细胞浸润及对免疫治疗的反应。
Clin Epigenetics. 2025 May 30;17(1):88. doi: 10.1186/s13148-025-01897-x.
7
Epigenetic Therapies in Melanoma-Targeting DNA Methylation and Histone Modification.黑色素瘤中的表观遗传疗法——靶向DNA甲基化和组蛋白修饰
Biomedicines. 2025 May 13;13(5):1188. doi: 10.3390/biomedicines13051188.
8
DNMT1-Induced Downregulation of CBX7 Inhibits ERK Phosphorylation and Promotes Pancreatic Ductal Adenocarcinoma Progression.DNMT1诱导的CBX7下调抑制ERK磷酸化并促进胰腺导管腺癌进展。
FASEB J. 2025 May 31;39(10):e70571. doi: 10.1096/fj.202402903R.
9
Tumors and their microenvironments: Learning from pediatric brain pathologies.肿瘤及其微环境:从儿童脑部病理学中学习。
Biochim Biophys Acta Rev Cancer. 2025 Jul;1880(3):189328. doi: 10.1016/j.bbcan.2025.189328. Epub 2025 Apr 18.
10
Management of T-cell malignancies: Bench-to-bedside targeting of epigenetic biology.T细胞恶性肿瘤的管理:从 bench 到床边的表观遗传生物学靶向治疗
CA Cancer J Clin. 2025 Jul-Aug;75(4):282-307. doi: 10.3322/caac.70001. Epub 2025 Apr 15.